Exemple: Heart Attack

Recherche d'essais cliniques pour: Oxymorphone

30 résultats au total

NCT00765856

Interrompue

Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects

Conditions: Chronic Pain
NCT01210638

Terminé

Bioequivalency Study of Oxymorphone Hydrochloride 10 mg Tablets Under Fasted Conditions

Conditions: Pain
NCT02687451

Interrompue

Clinical Study to Evaluate the Effectiveness, Safety, and Tolerability of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects

Conditions: Post-Operative Pain; Acute Pain
NCT00580294

Terminé

A Pilot Study of Switching From One Pain Medication to Another (Opioid Rotation)

Conditions: Pain
NCT00801398

Terminé

Open-Label Safety and Tolerability Study of Oxymorphone for Acute Postoperative Pain in Pediatric Subjects.

Conditions: Postoperative Pain
NCT01210352

Terminé

Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects

Conditions: Post Operative Pain
NCT00857428

Terminé

Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fasted Conditions

Conditions: Pain
NCT00930943

Terminé

Effect of Extended-release Oxymorphone Taking With or Without Food on Cognitive Functioning

Conditions: Chronic Pain
NCT00911261

Terminé

Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain

Conditions: Chronic Pain; Neuropathic Pain; Cancer
NCT00911287

Terminé

Oxymorphone Extended Release (ER) in Opioid-Naive Patients With Chronic Pain

Conditions: Pain; Chronic Disease
NCT01206907

Retirée

Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Opioid Tolerant Pediatric Subjects

Conditions: Chronic Pain
NCT04681027

Suspendu

Safety, Tolerability, Effectiveness, and Pharmacokinetic Data in Opioid-experienced Children

Conditions: Chronic Pain; Postsurgical Pain
NCT00857142

Terminé

Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fed Conditions

Conditions: Pain
NCT00945919

Statut inconnu

A Pilot Study of Ultra Rapid Opioid Rotation and Titration of Oxymorphone

Conditions: Chronic Nociceptive Pain; Neuropathic Pain; Non-cancer Pain
NCT00226395

Terminé

Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute Pain

Conditions: Acute Pain
NCT00226421

Terminé

Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain

Conditions: Chronic Pain
NCT00904280

Terminé

Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy

Conditions: Cancers, Pain; Lower Back Pain
NCT00904085

Terminé

Post-operative Efficacy and Safety Study

Conditions: Post-operative Pain
NCT03389750

Recrutement

A Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists.

Conditions: Opioid-use Disorder; Opioid Abuse
NCT00955110

Terminé

Study to Compare Oxymorphone Extended-Release (Opana ER) Versus Oxycodone Controlled-Release (Oxycontin)

Conditions: Healthy
NCT00225797

Terminé

Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain

Conditions: Chronic Pain
NCT00904449

Terminé

Open Label Assessment of Long-Term Safety and Utility

Conditions: Pain
NCT02741076

Interrompue

Discontinuation vs Continuation of Long-term Opioid Therapy in Suboptimal and Optimal Responders With Chronic Pain

Conditions: Opioid-Related Disorders; Opiate Addiction; Narcotic Abuse; Drug Abuse
NCT00652093

Interrompue

Lumbar Stenosis Outcomes Research II

Conditions: Lumbar Spinal Stenosis
NCT03579446

Recrutement

Levorphanol as a Second Line Opioid in Cancer Patients

Conditions: Malignant Neoplasm; Metastatic Malignant Neoplasm